17-Apr-2014 - AMRI says its long-term outlook remains positive with continued demand for its contract research services despite plans to shutter a Discovery and Development Services facility.
08-Apr-2014 - CRO Evotec AG will help Debiopharm identify and develop novel compounds with the potential to treat multiple forms of solid tumours and leukaemias with defined genetic alterations under a collabortation announced...
02-Apr-2014 - Argenta and BioFocus will add approximately $70m (€51m) to Charles River Laboratories’ 2014 revenues, the firm and an analyst say.
01-Apr-2014 - Convergence Pharmaceuticals has entered into a research alliance with CRO Evotec to discover and develop compounds against a novel GPCR pain target.
27-Mar-2014 - Demand from biotech firms and Big Pharma’s need to refill its pipeline is driving the preclinical services industry, say analysts at this year’s Society of Toxicology (SOT) meeting.
26-Mar-2014 - BioReliance has updated its big blue assay for the second time in six months by creating a version of the drug genotoxicity test that can be used in rats.
26-Mar-2014 - GSK has asked Formula One team Mclaren to help it discover drugs, arguing that Big Data expertise from outside the contract research sector can accelerate its efforts to develop new...
25-Mar-2014 - Covance has announced that its recently expanded large molecule bioanalytical space at its laboratory facility in Indianapolis will come online in late 2014.
24-Mar-2014 - Evotec AG has bought an asset management company that specialises in bringing academic discovery and development innovations to the attention of pharma and biopharma sponsors.
17-Mar-2014 - Pharmaceutical companies need to change their attitudes to contractors, says the former director of Shire’s relationships with its 100 outsourcing partners.
13-Mar-2014 - Preclinical CRO Charles River Labs has announced plans to buy discovery services firms Argenta and BioFocus from Galapagos NV.
05-Mar-2014 - Harlan is looking to take advantage of a dearth of new products in pharma clients’ pipelines with an early drug development partnership with France’s Bertin Pharma.
04-Mar-2014 - Clinical research group Venn Life Sciences has acquired the rights to LabSkin (pictured), a human skin substitute that behaves like the real thing, from dermatology CRO Evocutis.
27-Feb-2014 - Novartis says it will continue to spend around $1m a week on clinical trials in the UK after its R&D site closes in June.
27-Feb-2014 - With a drive towards personalised medicine, Big Pharma is acting like mini-biotech firms in its approach to R&D, says Horizon Discovery who is launching a £25m ($42m) IPO.
20-Feb-2014 - CRO Charles River Laboratories launched today a new insourcing/outsourcing option for its clients to improve their quality control.
18-Feb-2014 - Canadian CRO ADA Medical will collaborate with Italy’s Ephoran Multi-Imaging Solutions to expand into the pre-clinical research space.
12-Feb-2014 - MPI Research, inviCRO and 3D Imaging have partnered to build a Translational Imaging Center, providing molecular imaging, autoradiography, and animal modelling for pharmaceutical clients to investigate drug candidates.
12-Feb-2014 - Charles River Laboratories says it will shutter a Research Models and Services (RMS) facility in Michigan as softened demand for the sector offset a strong year for its preclinical service...
11-Feb-2014 - The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s...
05-Feb-2014 - Covance has sold its high-complexity genomics laboratory to LabCorp as part of what an analyst says is decisive action to shed underperforming assets in its Early Development business.
21-Jan-2014 - CRO Harlan Laboratories announced that it will open its first oncology research model breeding facility in India, which has already sparked anger in the animal rights community.
21-Jan-2014 - Sigma-Aldrich has teamed with Biopredic to produce genetically-modified human liver cell lines and assays it says can cut costs by reducing animal toxicology studies in drug discovery.
20-Jan-2014 - Strategic relationships with both big pharma and mid-tier firms will drive future growth, says Charles River laboratories (CRL).
16-Jan-2014 - As part of its shift to cut costs, Covance has demolished an unfinished $175m (€128m) toxicology laboratory it was building in Manassas, Virginia.